Circular RNA profiling identified as a biomarker for predicting the efficacy of Gefitinib therapy for non-small cell lung cancer

BACKGROUND: Epidermal growth factor receptor tyrosine kinase inhibitors (EGFR-TKIs) have become important treatment options for non-small cell lung cancer (NSCLC) patients with EGFR sensitive mutation. However, the detection of EGFR driver mutation is impeded by the lack of adequate tumor tissues, h...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:J Thorac Dis
Asıl Yazarlar: Liu, Yu-Tao, Han, Xiao-Hong, Xing, Pu-Yuan, Hu, Xing-Sheng, Hao, Xue-Zhi, Wang, Yan, Li, Jun-Ling, Zhang, Zhi-Shang, Yang, Zhi-Hao, Shi, Yuan-Kai
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: AME Publishing Company 2019
Konular:
Original Article
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC6588778/
https://ncbi.nlm.nih.gov/pubmed/31285870
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.21037/jtd.2019.05.22
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller